72.20
1.24 (1.75%)
| Previous Close | 70.96 |
| Open | 72.29 |
| Volume | 3,562,198 |
| Avg. Volume (3M) | 3,414,018 |
| Market Cap | 32,944,146,432 |
| Price / Earnings (TTM) | 15.87 |
| Price / Earnings (Forward) | 13.89 |
| Price / Sales | 1.56 |
| Price / Book | 3.09 |
| 52 Weeks Range | |
| Earnings Date | 29 Apr 2026 |
| TTM Dividend Yield | 0.19% |
| Profit Margin | 11.03% |
| Operating Margin (TTM) | 14.78% |
| Diluted EPS (TTM) | 4.76 |
| Quarterly Revenue Growth (YOY) | 2.70% |
| Quarterly Earnings Growth (YOY) | 50.80% |
| Total Debt/Equity (MRQ) | 97.51% |
| Current Ratio (MRQ) | 0.980 |
| Operating Cash Flow (TTM) | 1.78 B |
| Levered Free Cash Flow (TTM) | 1.58 B |
| Return on Assets (TTM) | 5.87% |
| Return on Equity (TTM) | 26.44% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | GE HealthCare Technologies Inc. | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 3.0 |
| Insider Activity | 1.5 |
| Price Volatility | 1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | 0.60 |
|
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%). |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Core |
| % Held by Insiders | 0.28% |
| % Held by Institutions | 80.26% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 98.00 (Stifel, 35.73%) | Buy |
| 98.00 (Evercore ISI Group, 35.73%) | Buy | |
| Median | 91.50 (26.73%) | |
| Low | 77.00 (UBS, 6.65%) | Sell |
| Average | 90.30 (25.07%) | |
| Total | 5 Buy, 4 Hold, 1 Sell | |
| Avg. Price @ Call | 80.81 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 11 Mar 2026 | 84.00 (16.34%) | Hold | 72.65 |
| BTIG | 09 Feb 2026 | 91.00 (26.04%) | Buy | 79.08 |
| 04 Feb 2026 | 91.00 (26.04%) | Buy | 82.63 | |
| Barclays | 06 Feb 2026 | 87.00 (20.50%) | Hold | 80.65 |
| Evercore ISI Group | 05 Feb 2026 | 98.00 (35.73%) | Buy | 82.31 |
| Morgan Stanley | 05 Feb 2026 | 85.00 (17.73%) | Hold | 82.31 |
| Stifel | 05 Feb 2026 | 98.00 (35.73%) | Buy | 82.31 |
| 07 Jan 2026 | 95.00 (31.58%) | Buy | 85.76 | |
| Wells Fargo | 05 Feb 2026 | 97.00 (34.35%) | Buy | 82.31 |
| Piper Sandler | 30 Jan 2026 | 94.00 (30.19%) | Buy | 78.97 |
| UBS | 15 Jan 2026 | 77.00 (6.65%) | Sell | 82.51 |
| B of A Securities | 05 Jan 2026 | 92.00 (27.42%) | Hold | 85.04 |
| Show more | ||||
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 04 Feb 2026 | Announcement | GE HealthCare reports fourth quarter and full year 2025 financial results |
| 02 Feb 2026 | Announcement | GE HealthCare announces U.S. FDA 510(k) clearance and CE Mark for Allia Moveo and marks first global installation, advancing precision care in the interventional suite |
| 06 Jan 2026 | Announcement | GE HealthCare Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited |
| 06 Jan 2026 | Announcement | NXP and GE HealthCare Accelerate AI Innovation in Acute Care |
| 05 Jan 2026 | Announcement | GE HealthCare to announce fourth quarter and full year 2025 results on February 4, 2026 |
| 29 Dec 2025 | Announcement | GE HealthCare management to present at upcoming investor conference |
| TTM Dividend Yield | 0.19% |
| 3Y Average Dividend Yield | 0.15% |
| Payout Ratio | 2.63% |
| Expected Next Dividend Payment | Aug 2026 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 02 Apr 2026 | 12 Feb 2026 | 15 May 2026 | 0.035 Cash |
| 09 Jan 2026 | 24 Nov 2025 | 13 Feb 2026 | 0.035 Cash |
| 24 Oct 2025 | 24 Sep 2025 | 14 Nov 2025 | 0.035 Cash |
| 25 Jul 2025 | 01 Jul 2025 | 15 Aug 2025 | 0.035 Cash |
| 25 Apr 2025 | 27 Mar 2025 | 15 May 2025 | 0.035 Cash |
| 14 Jan 2025 | 21 Nov 2024 | 14 Feb 2025 | 0.035 Cash |
| 18 Oct 2024 | 18 Sep 2024 | 15 Nov 2024 | 0.03 Cash |
| 19 Jul 2024 | 26 Jun 2024 | 15 Aug 2024 | 0.03 Cash |
| 18 Apr 2024 | 22 Mar 2024 | 15 May 2024 | 0.03 Cash |
| 12 Jan 2024 | 08 Dec 2023 | 15 Feb 2024 | 0.03 Cash |
| 19 Oct 2023 | 22 Sep 2023 | 15 Nov 2023 | 0.03 Cash |
| 20 Jul 2023 | 23 Jun 2023 | 15 Aug 2023 | 0.03 Cash |
| 22 May 2023 | 25 Apr 2023 | 15 Jun 2023 | 0.03 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2026 | 0.070 | 2 | 0.10 |
| 2025 | 0.140 | 4 | 0.17 |
| 2024 | 0.120 | 4 | 0.15 |
| 2023 | 0.090 | 3 | 0.12 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |